BRFXF - B-COMPLEX VITAMIN
- MSDS: BRFXF
- Manufacturer: FUJISAWA PHARMACEUTICAL CO
- Product Name: B-COMPLEX VITAMIN
- National Stock Number: 6505-01-354-7013
Product Identification
Product ID:B-COMPLEX VITAMIN
MSDS Date:01/01/1994
FSC:6505
NIIN:01-354-7013
MSDS Number: BRFXF
Responsible Party
DEERFIELD, IL 60015-2548
US
Emergency Phone: 800-888-7704
Info Phone: 708-317-0800
Preparer: CHRISTINA J. BARRINGTON
Cage: EO410
Contractor
Telephone: 312-345-6170
Cage: 60567
Ingredients
THIAMINE HYDROCHLORIDE - 200 MG/VIAL
CAS: 67-03-8
RTECS: XI7350000
RIBOFLAVIN - 30 MG/VIAL
CAS: 83-88-5
RTECS: VJ1400000
PYRIDOXINE HYDROCHLORIDE - 50 MG/VIAL
CAS: 58-56-0
RTECS: UV1350000
DEXPANTHENOL - 50 MG/VIAL
CAS: 81-13-0
RTECS: ES4316000
NIACINAMIDE - 750 MG/VIAL
CAS: 98-92-0
RTECS: QS3675000
CYANOCOALAMIN - 10,000 MICROGRAMS/VIAL
CAS: 68-19-9
RTECS: GG3750000
ASCORBIC ACID - 1000 MG/VIAL
CAS: 50-81-7
RTECS: CI7650000
OSHA PEL NOT EXTABLISHED
BENZYL ALCOHOL
CAS: 100-51-6
RTECS: DN3150000
Fraction By Weight: 0.9%
METHYL PARABEN - 18 MG/VIAL
CAS: 99-76-3
RTECS: DH2450000
PROPYL PARABEN - 2 MG/VIAL
CAS: 94-13-3
RTECS: DH2800000
SODIUM METABISULFITE - 1 MG/VIAL
CAS: 7681-57-4
RTECS: UX8225000
OSHA PEL 5 MG/M3
ACGIH TLV: 5 MG/M3; 9293
WATER
CAS: 7732-18-5
RTECS: ZC0110000
SULFURIC ACID (SARA III) USED ONLY WHEN PH ADJUSTMENT IS
CAS: 7664-93-9
RTECS: WS5600000
OSHA PEL 1 MG/M3
ACGIH TLV: 1 MG/M3; 9293
EPA Report Quantity: 1000 LBS
DOT Report Quantity: 1000 LBS
SODIUM HYDROXIDE (SARA III) USED ONLY WHEN PH ADJUSTMENT
CAS: 1310-73-2
RTECS: WB4900000
OSHA PEL 2 MG/M3
ACGIH TLV: C 2 MG/M3; 9293
EPA Report Quantity: 1000 LBS
DOT Report Quantity: 1000 LBS
Hazards
LD50 LC50 Mixture:LD50: NOT GIVEN
Routes of Entry: Inhalation:YES Skin:YES Ingestion:YES
Reports of Carcinogenicity:NTP:NO IARC:NO OSHA:NO
Health Hazards Acute and Chronic:EYE, SKIN AND RESPIRATORY IRRITATION
MAY OCCUR. NOTE: PRODUCT INTENDED FOR THERAPEUTIC USE ONLY WHEN
PRESCRIBED BY A PHYSICIAN.
Explanation of Carcinogenicity:THIS COMPOUND CONTAINS NO INGREDIENTS AT
CONCENTRATIONS OF 0.1% OR GREATER THAT ARE CARCINOGENS OR SUSPECT
CARCINOGENS.
Effects of Overexposure:EYE IRRITATION, SKIN IRRITATION, RESPIRATORY
IRRITATION
Medical Cond Aggravated by Exposure:PRE-EXISITNG SKIN AND RESPIRATORY
CONDITIONS MAY BE ADVERSELY AFFECTED BY EXPOSURE.
First Aid
First Aid:INHALATION: MOVE PERSON TO FRESH AIR IMMEDIATELY. GIVE
ARTIFICIAL RESPIRATION AND CPR IF REQUIRED. SEEK MEDICAL ATTENTION.
INGESTION: FLUSH MOUTH WITH WATER IMMEDIATELY. SEEK MEDICAL
ATTENTION. SKIN: REMOVE CONTAMINATED CLOTHING IMMEDIATELY. FLUSH
AREA WITH WATER. SEEK MEDICAL ATTENTION. EYES: IMMEDIATELY FLUSH
WITH WATER FOR AT LEAST 15 MINUTES. SEEK MEDICAL ATTENTION.
Fire Fighting
Flash Point:NONFLAMMABLE
Lower Limits:NOT GIVEN
Upper Limits:NOT GIVEN
Extinguishing Media:WATER SPRAY, DRY CHEMICAL, CARBON DIOXIE OR FOAM AS
APPRORPIATE
Fire Fighting Procedures:WEAR FIRE FIGHTING PROTECTIVE EQUIPMENT AND
FULL FACE-PIECE SELF-CONTAINED BREATHING APPARATUS.
Unusual Fire/Explosion Hazard:WHEN HEATED TO DECOMPOSITION IT EMITS
TOXIC FUMES.
Accidental Release
Spill Release Procedures:WEAR RECOMMENDED PERSONAL PROTECTIVE
EQUIPMENT. USE ABSORBENT TOWELS OR BOOMS TO CLEAN-UP SPILL. WIPE
SURFACES CLEAN AND WASH WITH SOAP AND WATER.
Neutralizing Agent:NONE SPECIFIED BY MANUFACTURER.
Handling
Handling and Storage Precautions:WHEN HANDLING PHARMACEUTICAL PRODUCTS,
AVOID ALL CONTACT AND INHALATION OF DUST, FUMES, MISTS AND/OR VAPOR
ASSOCIATED WITH THE PRODUCT.
Other Precautions:FOR ADVERSE DRUG REACTION INFORMATION, CALL
708-317-5937.
Exposure Controls
Respiratory Protection:WITH SATISFACTORY VENTILATION, RESPIRATORY
PROTECTION NOT USUALLY REQUIRED.
Ventilation:GENERAL ROOM VENTILATION IS USUALLY SATISFACTORY, USE LOCAL
EXHAUST VENTIALTION WHEN NECESSARY.
Protective Gloves:DISPOSABLE LATEX
Eye Protection:SAFETY GLASSES OR GOGGLES
Other Protective Equipment:DISPOSABLE GARMENTS IF DIRECT SKIN CONTACT
IS ANTICIPATED.
Work Hygienic Practices:WASH WITH SOAP AND WATER AFTER HANDLING PRODUCT
AND BEFORE EATING DRINKING OR SMOKING.
Supplemental Safety and Health
POTENTIAL ADVERSE REACTIONS FROM PRESCRIBED DOSES AND OVERDOSES ARE
DESCRIBED MORE FULLY IN THE PACKAGE INSERT. OCCUPATIONL EXPOSURE
HAS NOT BEEN FULLY INVESTIGATED.
Chemical Properties
HCC:N1
NRC/State Lic Num:NONE
Boiling Pt:B.P. Text:NOT GIVEN
Melt/Freeze Pt:M.P/F.P Text:NOT GIVEN
Vapor Pres:NOT GIVEN
Vapor Density:NOT GIVEN
Spec Gravity:NOT GIVEN
Evaporation Rate & Reference:NOT GIVEN
Solubility in Water:SOLUBLE
Appearance and Odor:COVIAL, RED SOLUTION UPPER CHAMBER AND YELLOW
POWDER LOWER CHAMBER.
Stability
Stability Indicator/Materials to Avoid:YES
NONE SPECIFIED BY MANUFACTURER.
Stability Condition to Avoid:PROTECT FROM FREEZING
Hazardous Decomposition Products:SMOKE
Disposal
Waste Disposal Methods:PREVENT WASTE FROM CONTAMINATING SURROUNDING
ENVIRONMENT. DISCARD ANY PRODUCT, RESIDUE, DISPOSAL CONTAINER OR
LINER IN ACCORDANCE WITH ALL FEDERAL, STATE AND LOCAL REGULATIONS.
Disclaimer (provided with this information by the compiling agencies):
This information is formulated for use by elements of the Department
of Defense. The United States of America in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. Any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.